IR strategy at Switzerland's largest multinational
New skills, or in Latin, novae artes. More than a brand name, it's a pledge to keep innovating by one of the global leaders in pharmaceuticals, Novartis, the Swiss giant born out of the 1996 merger of Ciba and Sandoz. Headquartered in Basel, Switzerland, Novartis has steadily developed a reputation as a solid, well-performing company that continues to grow despite an up and down market. Its annual sales were over $20 bn last year and it has a current market capitalization of about $107 bn,
You need to register to access 3 free deep dive articles per month. To continue reading please register or login below..
- Unlimited deep dives
- Data-driven research around key topics
- Buy-side insights
- Benchmarking reports
From
$1495